In this week’s Homerun Slides, EMPA-REG Outcome, examining the long-term effects of empagliflozin versus using a placebo on the heart and mortality risk in patients with type 2.
To download the complete set in PowerPoint format, just use this link:
EMPA-REG Outcome Trial Part 2, (long-term effects of empagliflozin)
Catch up on past Homerun Slides for the EMPA-REG Outcome series.
To download part 1, click here: EMPA-REG Outcome Trial Part 1